Russell Investments Group, Ltd. - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$10,653
-40.8%
864
-81.6%
0.00%
Q4 2018$18,000
-28.0%
4,7000.0%0.00%
Q3 2018$25,000
-95.2%
4,700
-95.6%
0.00%
-100.0%
Q2 2018$521,000
-39.2%
106,064
-0.4%
0.00%0.0%
Q1 2018$857,000
-12.7%
106,464
+14.5%
0.00%
-50.0%
Q4 2017$982,00092,9800.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Newtyn Management, LLC 633,297$3,109,0000.58%
BVF INC/IL 1,110,588$5,453,0000.53%
WITTENBERG INVESTMENT MANAGEMENT, INC. 253,752$1,246,0000.53%
Rubric Capital Management LP 476,164$2,338,0000.23%
Clearline Capital LP 59,331$291,0000.19%
Yakira Capital Management, Inc. 66,934$329,0000.08%
KEMPNER CAPITAL MANAGEMENT INC. 14,898$73,0000.05%
STONEBRIDGE CAPITAL MANAGEMENT INC 20,725$106,0000.04%
J. Goldman & Co LP 100,000$491,0000.02%
Dynamic Technology Lab Private Ltd 22,731$112,0000.02%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders